INTRODUCTION
Babesiosis is a disease caused by unicellular Babesia parasites that infect vertebrates. The parasites are transmitted by arthropod vectors and invade and proliferate in red blood cells. In almost every host species a large and a small Babesia species has been found and formerly, in dogs only a single small Babesia (B. gibsoni) and a single large Babesia (B. canis) were described 12 . With the advent of molecular biological techniques, however, the number of small and large Babesia species has increased and presently at least 3 different small canine Babesia species are recognised and 4 large canine Babesia species 32 . Two of the large species, B. canis and B. rossi, have been subject to scientific research for almost a century and biological differences have been described. This review aims to bring together data obtained for the respective species in order to shed light on differences and similarities between these parasites with emphasis on the impact of this on vaccine-induced immunity in dogs.
LARGE BABESIA SPECIES THAT INFECT DOGS
Babesia canis and B. rossi are the large parasites that cause most of the clinical problems in dogs in Europe 3 and South Africa 11 respectively. There have been scattered reports on clinical cases due to B. vogeli, and now it seems that this parasite is more globally distributed, with reports coming from Australia, Asia, America, South Africa, Brazil and Europe (reviewed 33 ). Geographical distribution and vector specificity (each of these 3 large Babesia species appears to be transmitted by its 'own' tick vector) argue in favour of a taxonomic differentiation at the species level. However, cross-protection studies have lent support to a subspecies classification 32 . 22 ). Although it is claimed that vaccines that contain SPA derived from serum of infected animals provide a broad spectrum of immunity 31 , this was not obtained with vaccines containing SPA derived from in vitro cultures. With the latter vaccines, protective immunity against homologous challenge was obtained, but less so against heterologous challenge 22 . In general, the nature of immunity obtained by vaccination with plasma/ serum-derived SPA is reflected in shorter duration of patent parasitaemia and reduced peak parasitaemia in the circulation 31 . However, results from studies with SPA from supernatants of in vitro cultures of B. canis showed that protection against clinical disease can be induced without an apparent effect on parasite proliferation 23 . This suggests that Babesia parasites release molecules that are pathogenic, and that this activity can be diminished by vaccineinduced antibodies that neutralise pathogenic molecules and/or vaccine-induced anti-parasite activity that reduces the production of such pathogenic molecules. The protective activity of SPA derived from B. canis, demonstrated in the 1980s, led to the development of a commercially available vaccine in Europe 18 . Preliminary experiments using SPA of B. rossi to vaccinate dogs against challenge infection were disappointing 13 . Additional studies confirmed these results 29 . A deeper understanding of the differences between B. canis and B. rossi could give insight into the nature of vaccine-induced immunity and explain variable results obtained with SPA-based vaccines.
COMPARISON OF B. CANIS AND B. ROSSI ISOLATES

Characterisation of infected erythrocytes in vitro
Babesia canis and B. rossi cannot be distinguished by examination of Giemsastained blood smears: both are large parasites and the morphology (ring, trophozoites, merozoite) is comparable (Fig. 1) .
Using atomic-force microscopy, structural alterations of the erythrocyte surface were observed in bovine erythrocytes that were infected with B. bovis parasites 9 . These structures had been demonstrated before using electron microscopy and are called knob-like protrusions 10 . They are considered to be analogous to the knobs on Plasmodium falciparum-infected erythrocytes and possibly play a crucial role in sequestration of infected erythrocytes in the microvasculature 2, 26 . Structural alterations such as knob-like protrusions could not be detected by atomic-force microscopy on canine red blood cells that were infected with mature dividing forms of either B. canis or B. rossi isolates (Fig. 1) . Any difference in sequestration profile of B. canis and B. rossi (see below) therefore cannot be simply related to the presence of knob-like structures.
By contrast, canine red blood cells that were infected with B. canis parasites showed biochemical differences when compared with red blood cells infected with B. rossi parasites; B. canis-infected red blood cells could be partially purified over Plasmagel whereas B. rossi-infected erythrocytes could not 24 . It was also noted that B. canis-infected erythrocytes tended to autoagglutinate in vitro whereas B. rossi-infected erythrocytes did not (K. Moubri, pers. comm.). Nothing is known about the nature of this difference, and 2 possibilities are considered: either there is a real biochemical difference in the molecules that make up the erythrocyte membrane, or the infected erythrocyte is coated with an as yet unidentified molecule (or molecules). It is also unknown whether this putative molecule is parasite-derived or a host molecule, produced perhaps during the inflammatory response, as has been suggested in B. bovis infections 34 . There is ample evidence of an inflammatory response in animals that are infected with Babesia parasites, which is associated with increased levels of fibrinogen (in dogs known as an acutephase protein 7, 16, 20 ) . It has been suggested that erythrocytes may become coated with fibrinogen (or fibrinogen-like molecules), which increases the propensity to autoagglutinate. In-saline autoagglutination, which is observed in a proportion of clinical cases, could reflect such coating of B. rossi-infected erythrocytes, but this has not been proven yet 11 . Antigenic differences between B. canis and B. rossi isolates have been shown using immunofluorescence on fixed blood smears 32 and immunoblotting 8 . Using immunofluorescence (in which mainly merozoites become fluorescent), there was considerable cross-reactivity between the 2 isolates, but titres against homologous antigens were the highest 32 . An alternative immunofluorescence test in which infected red blood cells were not fixed prior to incubation with specific antisera (which focuses on reactivity against the infected erythrocyte membrane 1 ) revealed a more distinct pattern: B. rossi-infected erythrocytes reacted only with B. rossi-specific antiserum and not with an antiserum that stained all B. canis-infected red blood cells and vice versa 24 (Table 1) . It was concluded that B. canis and B. rossi infected erythrocytes expose species-specific epitopes at the cell surface.
Analysis of B. canis and B. rossi infections in dogs
Apart from the fact that there may be differences in virulence depending on the particular isolate studied 14 indicated that breed, but not age or sex, was specifically associated with clinical disease 15 . By contrast, in a large-scale survey of clinically affected dogs in South Africa, it was shown that age had a significant effect on the main clinico-pathological findings 20 . In order to compare the virulence of different Babesia parasites in dogs, controlled experimental infections in age-matched animals of a single breed are indispensable. In a small-scale study, Uilenberg showed that the B. rossi isolate was highly pathogenic and irrespective of whether the dogs had survived infection with B. canis, they all had to be treated to prevent them from succumbing to the infection. By contrast, dogs that were infected with B. canis appeared less affected 32 . Additional studies using the same parasite isolates and age-matched experimental groups also indicated that the B. rossi isolate was more virulent than the B. canis isolate, in that B. rossi-infected dogs developed progressive parasitaemia that required early treatment (at day 7 after infection), whereas B. canis-infected dogs showed a limited transient parasitaemia that did not require early treatment 24 . The simplest explanation is that dogs that are infected with B. canis effectively control the parasite, whereas dogs infected with B. rossi do not. If this were the case one would expect to find a correlation between the time point of apparent control of parasitaemia and recovery from clinical signs. This has not been found in experimental B. canis infections 24 . Apparently, other mechanisms are involved. Since a proportion of the infected erythrocytes sequesters in the microvasculature in both B. canis and B. rossi infections 11 , a difference in the tendency of infected erythrocytes to sequester in the microvasculature may be associated with virulence. The mechanisms involved in such sequestration are not clear, but do not seem to require the presence of knob-like structures as seen in B. bovis infections in cattle (see above). It has been hypothesised that this difference in virulence is a qualitative difference, i.e. infection with B. rossi triggers different reactions in the host compared with B. canis, for instance the induction of fibrinogen 25 . Fibrinogen increase was higher in B. canis infection than in B. rossi infection and, if coating of infected erythrocytes with fibrinogen predisposes sequestration, this could offer an explanation for the difference in parasitaemia 24 .
VACCINATION AGAINST B. CANIS AND B. ROSSI USING SPA
Soluble parasite antigens of supernatants from in vitro cultures have been successfully used to vaccinate animals against challenge with homologous Babesia parasites, including vaccination of dogs against B. canis 22 . Vaccination against the South African B. rossi parasite has been less successful 13 and even repeated vaccination with SPA did not improve vaccine efficacy 29 . This does not necessarily mean that clinical disease caused by B. rossi infection is not due to reactions triggered by SPA; it shows that vaccination with SPA in combination with a saponin adjuvant is not able to induce a protective immune response. These results indicate that indeed B. rossi differs from B. canis immunobiologically, which could be reflected in (immuno-) biochemical differences found in in vitro assays (see above) 24 . In the case of B. canis infection, the spectrum of immunity obtained after vaccination with SPA of B. canis could be broadened by adding SPA of B. rossi 27 . Dogs that were vaccinated with the bivalent vaccine preparation showed significant protection upon challenge with a heterologous B. canis parasite (vaccine production has been described in detail previously 30 ). As for the monovalent vaccine, the nature of immunity appeared to be anti-disease i.e. protection could be shown in dogs without an apparent effect on parasitaemia 28 . This could be explained assuming that the vaccinated animals produced neutralising antibodies against the putative toxic component(s) of SPA upon experimental challenge infection. Although not completely elucidated, the result suggested that this bivalent antigen preparation stimulates immune responsiveness against cross-reactive epitopes that are shared between B. canis and B. rossi SPA, thus transcending the species specificity 27 . This posed the question whether this vaccine preparation could also induce immunity against B. rossi challenge infection. Indeed, although the monovalent vaccine based on B. rossi SPA only did not induce protection, the bivalent preparation was effective against a homologous as well as heterologous B. rossi challenge infection 29 . Surprisingly, the protective effect that was expressed as reduced clinical signs correlated with a reduction of parasitaemia; in dogs that had received 3 vaccinations not a single infected erythrocyte was detected in blood smears taken after challenge infection. The level of SPA in plasma after challenge infection was reduced likewise and probably the result of reduced parasitaemia (less production) and/or antibody reactivity against SPA (neutralisation) 29 . This leaves, amongst others, the possibility that SPA also induces pathology in B. rossi infection. SPA preparations are complex mixtures of parasite and host molecules that are poorly characterised and little is known at the molecular level 17, 21 . Clearly more research is needed to explain the results obtained so far.
CONCLUSIONS
The clinical picture of dogs infected with either of the 2 most virulent large Babesia species that infect dogs, B. canis and B. rossi, is highly diverse. Data from the field and from experimental studies suggest that B. rossi is more virulent than B. canis; however, some of the data can be explained by the variability in virulence of individual isolates. Vaccination with a bivalent vaccine containing soluble parasite antigen (SPA) from supernatants of in vitro cultures of B. canis and B. rossi induced protection against clinical babesiosis upon challenge infection with either parasite. The dynamics of parasitaemia upon challenge infection of vaccinated animals indicated a biological difference between the B. canis and B. rossi isolates studied. Apparently the nature of vaccine-induced immunity differs with respect to the challenge species. In order to fully understand the protective mechanisms, more detailed characterisation of SPA preparations and analysis of the immunoprotective effects of specific components need to be addressed.
